Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Shares Issued (2023 - 2025)

Historic Shares Issued for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $558000.0.

  • Nuvation Bio's Shares Issued fell 6658.68% to $558000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 1039.25%. This contributed to the annual value of $4.5 million for FY2024, which is 108880.0% up from last year.
  • Nuvation Bio's Shares Issued amounted to $558000.0 in Q3 2025, which was down 6658.68% from $762000.0 recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Shares Issued registered a high of $1.9 million during Q2 2024, and its lowest value of $21000.0 during Q1 2024.
  • Moreover, its 3-year median value for Shares Issued was $762000.0 (2025), whereas its average is $803888.9.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 9295.3% in 2024, then surged by 505238.1% in 2025.
  • Nuvation Bio's Shares Issued (Quarter) stood at $77000.0 in 2023, then skyrocketed by 990.91% to $840000.0 in 2024, then crashed by 33.57% to $558000.0 in 2025.
  • Its last three reported values are $558000.0 in Q3 2025, $762000.0 for Q2 2025, and $1.1 million during Q1 2025.